ConductScience.org, home

Trial · NCT03228680

Results by group156

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Oocytes RetrievedFE 999049 (Follitropin Delta)9.3Standard Deviation 5.4Oocytes retrieved
Number of Oocytes RetrievedFOLLISTIM (Follitropin Beta)10.5Standard Deviation 6.1Oocytes retrieved
Clinical Pregnancy RateFE 999049 (Follitropin Delta)25.3percentage of participants
Clinical Pregnancy RateFOLLISTIM (Follitropin Beta)23.7percentage of participants
Positive Beta Unit of Human Chorionic Gonadotropin (Beta-hCG) RateFE 999049 (Follitropin Delta)29.4percentage of participants
Positive Beta Unit of Human Chorionic Gonadotropin (Beta-hCG) RateFOLLISTIM (Follitropin Beta)29.4percentage of participants
Vital Pregnancy RateFE 999049 (Follitropin Delta)23.5percentage of participants
Vital Pregnancy RateFOLLISTIM (Follitropin Beta)21.5percentage of participants
Implantation RateFE 999049 (Follitropin Delta)31.9% of sacs/blastocysts transferred
Implantation RateFOLLISTIM (Follitropin Beta)29.8% of sacs/blastocysts transferred
Proportion of Participants With Cycle Cancellation Due to Poor or Excessive Ovarian ResponseFE 999049 (Follitropin Delta)Cycle cancelled due to poor ovarian response1.2percentage of participants
Proportion of Participants With Cycle Cancellation Due to Poor or Excessive Ovarian ResponseFOLLISTIM (Follitropin Beta)Cycle cancelled due to poor ovarian response0.6percentage of participants
Proportion of Participants With Cycle Cancellation Due to Poor or Excessive Ovarian ResponseFE 999049 (Follitropin Delta)Cycle cancelled due to excessive ovarian response0percentage of participants
Proportion of Participants With Cycle Cancellation Due to Poor or Excessive Ovarian ResponseFOLLISTIM (Follitropin Beta)Cycle cancelled due to excessive ovarian response1.1percentage of participants
Proportion of Participants With Blastocyst Transfer Cancellation Due to Excessive Ovarian Response / OHSS RiskFE 999049 (Follitropin Delta)7.6percentage of participants
Proportion of Participants With Blastocyst Transfer Cancellation Due to Excessive Ovarian Response / OHSS RiskFOLLISTIM (Follitropin Beta)11.3percentage of participants
Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes RetrievedFE 999049 (Follitropin Delta)Low response (<4 oocytes)8.3percentage of participants
Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes RetrievedFOLLISTIM (Follitropin Beta)Low response (<4 oocytes)5.2percentage of participants
Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes RetrievedFE 999049 (Follitropin Delta)Moderate response (4-7 oocytes)36.1percentage of participants
Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes RetrievedFOLLISTIM (Follitropin Beta)Moderate response (4-7 oocytes)26.6percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03228680/results